The newly published report by IMARC Group, titled ”Carotid Artery Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the carotid artery disease market size. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.
How big is the market for carotid artery disease?
The carotid artery disease market is anticipated to grow at a CAGR of 3.16% during 2023-2033.
Request for a Sample Report: https://www.imarcgroup.com/carotid-artery-disease-market/requestsample
What is carotid artery disease?
Carotid artery disease takes place when the carotid arteries, which provide oxygenated blood to the brain, become narrowed or blocked. Common symptoms are temporary episodes of neurological dysfunction like numbness, slurred speech, and vision changes, known as transient ischemic attacks. Other signs may include sudden severe headaches, dizziness, coordination difficulties, confusion, and facial drooping. If the disease progresses, this condition can lead to a complete blockage of blood flow and result in a stroke. Diagnosis involves evaluating medical history, conducting physical examinations, and utilizing various diagnostic tests such as carotid ultrasound, MRI, and computed tomography angiography to visualize the arteries and assess the extent of narrowing.
Explore the Full Report with Table of Contents: https://www.imarcgroup.com/carotid-artery-disease-market
What are the key drivers and trends in the carotid artery disease market?
The carotid artery disease market is experiencing growth due to the increasing prevalence of atherosclerosis, characterized by plaque buildup in artery walls and subsequent narrowing of the carotid arteries. This is further fueled by the rising incidence of risk factors like hypertension, diabetes, obesity, elevated LDL cholesterol levels, and inflammatory conditions such as rheumatoid arthritis. Additionally, the use of antiplatelet drugs, including clopidogrel and ticagrelor, to prevent blood clot formation in the carotid arteries is contributing to market expansion. The utilization of carotid endarterectomy, a surgical procedure that removes plaque to restore blood flow, in high-risk stroke patients is also propelling the market. Furthermore, advancements in endovascular techniques, including transcarotid artery revascularization and transradial carotid artery stenting, are expected to drive market growth in the future. These approaches are less invasive and carry a reduced risk of complications, providing a positive outlook for the carotid artery disease market.
What is included in the report segmentation?
The report covers the following aspects:
Base Year: 2022
Historical Period: 2017-2022
Market Forecast: 2023-2033
Analysis Covered Across Each Country
Historical, current, and future epidemiology scenario
Historical, current, and future performance of the carotid artery disease market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the carotid artery disease market
Reimbursement scenario in the market
In-market and pipeline drugs
Mechanism of Action
Clinical Trial Results
Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
Mechanism of Action
Clinical Trial Results
Ask an Analyst for Report Customization with Table of Contents: https://www.imarcgroup.com/request?type=report&id=7744&flag=C
How This Report Can Help You:
The report on carotid artery disease market presents a comprehensive overview and analysis of the epidemiology and market for this condition in the seven major markets (7MM): the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
With insights into both current and emerging therapies in the 7MM, this report offers valuable information for businesses seeking to understand trends and opportunities within the carotid artery disease market.
The carotid artery disease market report covers historical and forecasted market data, including epidemiology scenario, providing a reliable and informative resource for developing effective business strategies in 7MM.
Our report on the carotid artery disease market can help businesses stay abreast of the trends and drivers, gain a competitive edge and drive success.
Browse Our Latest Healthcare Research Report:
Key Questions Answered in this Report:
How has the carotid artery disease market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the carotid artery disease market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the carotid artery disease market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800